author-photo

X. Qiu

China Shipbuilding Industry Corporation

240

Papers

1209

Citations

Citation Trend

Filter By

Papers (240) Sort By

Journal Conference Others

Spectroscopy of $A=9$ hyperlithium by the $(e,e^{\prime}K^{+})$ reaction

2021 arXiv: Nuclear Experiment
Show All
- Source
- Cite
- Save
Citations (0)
HCMV prefusion gB in complex with fusion inhibitor WAY-174865

2021
Show All
- Source
- Cite
- Save
Citations (0)
Clinical evaluation of four different detection reagents for 2019-nCoV IgM and IgG antibodies in patients with COVID-19 and suspected cases

2021 Chinese Journal of Laboratory Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Infancy weight gain and neurodevelopmental outcomes among term-born infants at age one year: a large prospective cohort study in China

2021 Child Neuropsychology
Show All
- Source
- Cite
- Save
Citations (0)
A method for position offset correction of ship target on SAR image based on AIS data

2021 RadarCon | International Radar Conference
Show All
- Source
- Cite
- Save
Citations (0)
Prevalence and risk-factors of COVID-19 in pregnancy: Living systematic review and metaanalysis

2021 British Journal of Obstetrics and Gynaecology
Show All
- Source
- Cite
- Save
Citations (0)
MO01.43 Examining the Impact of Tislelizumab Added to Platinum Doublet Chemotherapy on Health-Related Quality of Life in Patients with Non-Squamous NSCLC

2021 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (0)
The impact of the COVID-19 pandemic on emergency gynaecological surgical practice;a review comparing the outcomes and safety of surgical practice- a single centre review

2021 British Journal of Obstetrics and Gynaecology
Show All
- Source
- Cite
- Save
Citations (1)
Peer Review #3 of "Genome-wide identification of HSF family in peach and functional analysis of PpHSF5 involvement in root and aerial organ development (v0.2)"

2021 PeerJ
- X. Qiu
Show All
- Source
- Cite
- Save
Citations (0)
1290P RATIONALE 304: Tislelizumab (TIS) plus chemotherapy (chemo) vs chemo alone as first-line (1L) treatment for non-squamous (non-sq) non-small cell lung cancer (NSCLC) in patients (pts) who are smokers vs non-smokers

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)